RAN-Irbesartan Product Recall (2021-05-27)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
A. RAN- Irbesartan 75mg Tablet
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| AB47146, | - Recalling Firm
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| B. RAN- Irbesartan 150mg Tablet | DIN 02406829 | Tablet | Irbesartan 150mg |
| AB47144, | - Recalling Firm
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| C. RAN- Irbesartan 300mg Tablet | DIN 02406837 | Tablet | Irbesartan 300mg |
| AB47143, | - Recalling Firm
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| A. RAN- Irbesartan 75mg Tablet | DIN 02406810 | Tablet | Irbesartan 75mg |
A. RAN- Irbesartan 75mg Tablet
B. RAN- Irbesartan 150mg Tablet
C. RAN- Irbesartan 300mg Tablet
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.